KPIs & Operating Metrics(New)
Growth Metrics

Charles River Laboratories International (CRL) Cash from Financing Activities: 2009-2024

Historic Cash from Financing Activities for Charles River Laboratories International (CRL) over the last 16 years, with Dec 2024 value amounting to -$550.9 million.

  • Charles River Laboratories International's Cash from Financing Activities rose 26.46% to -$152.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$560.7 million, marking a year-over-year decrease of 59.54%. This contributed to the annual value of -$550.9 million for FY2024, which is 544.20% down from last year.
  • Per Charles River Laboratories International's latest filing, its Cash from Financing Activities stood at -$550.9 million for FY2024, which was down 544.20% from -$85.5 million recorded in FY2023.
  • Charles River Laboratories International's Cash from Financing Activities' 5-year high stood at $672.6 million during FY2021, with a 5-year trough of -$550.9 million in FY2024.
  • For the 3-year period, Charles River Laboratories International's Cash from Financing Activities averaged around -$226.3 million, with its median value being -$85.5 million (2023).
  • As far as peak fluctuations go, Charles River Laboratories International's Cash from Financing Activities soared by 1,323.55% in 2021, and later tumbled by 544.20% in 2024.
  • Yearly analysis of 5 years shows Charles River Laboratories International's Cash from Financing Activities stood at $47.2 million in 2020, then spiked by 1,323.55% to $672.6 million in 2021, then tumbled by 106.30% to -$42.4 million in 2022, then tumbled by 101.71% to -$85.5 million in 2023, then slumped by 544.20% to -$550.9 million in 2024.